Finance

Lists
VYT:BME
Vytrus Biotech SA
€15,35
+1,99%
(+0,30) 1D
6 Okt., 17:36:00 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for VYT...
Open
€15,30
High
€15,35
Low
€15,00
Mkt. cap
114,02 m
Avg. vol.
2,12 k
Volume
425,00
P/E ratio
40,03
52-wk high
€20,60
52-wk low
€5,55
EPS
€0,38
Shares outstanding
7,64 m
No. of employees
44
Open
€15,30
High
€15,35
Low
€15,00
Mkt. cap
114,02 m
Avg. vol.
2,12 k
Volume
425,00
P/E ratio
40,03
52-wk high
€20,60
52-wk low
€5,55
EPS
€0,38
Shares outstanding
7,64 m
No. of employees
44
News stories
From web sources and news partners
About Vytrus Biotech SA
CEO-
Employees44
Founded2009
Headquarters-
SectorPersonal care products
Websitevytrus.com
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
Sep. 2024
Des. 2024
Sep. 2025
Revenue
1,53 m
1,53 m
2,33 m
Cost of goods sold
164,77 k
164,77 k
213,27 k
Cost of revenue
164,77 k
164,77 k
213,27 k
Research and development expenses
-
-
-
Total research and development expenses
-
-
-
Selling, general, and admin expenses
1,28 m
1,28 m
1,71 m
Operating expense
1,13 m
1,13 m
1,35 m
Total operating expenses
1,29 m
1,29 m
1,57 m
Operating income
236,08 k
236,08 k
766,56 k
Other non operating income
7,05 k
7,05 k
-1,87 k
EBT including unusual items
220,68 k
220,68 k
760,49 k
EBT excluding unusual items
220,49 k
220,49 k
760,98 k
Income tax expense
-34,46 k
-34,47 k
33,13 k
Effective tax rate
-15,62%
-15,62%
4,36%
Other operating expenses
-384,52 k
-384,52 k
-622,89 k
Net income
255,14 k
255,14 k
727,35 k
Net profit margin
16,69%
16,69%
31,19%
Earnings per share
-
-
-
Interest and investment income
5,86 k
5,86 k
16,47 k
Interest expense
-28,28 k
-28,28 k
-18,70 k
Net interest expenses
-22,42 k
-22,42 k
-2,23 k
Depreciation and amortization charges
228,17 k
228,16 k
263,45 k
EBITDA
330,31 k
284,10 k
880,59 k
Gain or loss from assets sale
-
-
-
AI content may include mistakes. Learn more
Google-programme